Skip to main content

J&J CEO Testifies In NJ Court Over Talcum Powder Trial

J&J CEO Testifies In NJ Court Over Talcum Powder Trial

J&J CEO Testifies In NJ Court Over Talcum Powder Trial

Introduction

Johnson & Johnson's Chief Executive Officer Alex Gorsky was called for the first time in the court, to testify in the lawsuit of the company's baby powder, causing cancer.

The lawsuit filed at a state courtroom in New Brunswick, New Jersey, near the company’s headquarters included three men and one woman. According to the lawsuit, all four plaintiffs are suffering from mesothelioma, a rare and incurable cancer. All four plaintiffs claim that they contracted cancer due to their exposure to asbestos in baby powder, which was applied when they were infants.

The jury held J&J liable for the plaintiffs’ cancers and awarded them $37.2 million in compensation in the early phase of the trial. Now the lawyers for plaintiffs are seeking to persuade a second jury claiming that punitive damages are necessary for the reckless behavior of J&J.

Gorsky testified that he was not aware of the safety measures of the powder as the issue can be traced back in 2012 before he joined the company. The attorneys for J&J responded to the statement by saying that they will look into the issue, which might result in dragging the previous executives to the court.

Currently, J&J faces 16,000 lawsuits against their baby powder. Lawsuits claim that the company failed to warn users about the contamination of powder because of asbestos.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!